BridgeMD
Tests treatment safety and results for Ulcer Venous
Official title Efficacy of a New Composition (BU002) for Debridement of Chronic Cutaneous Ulcers
ClinicalTrials.gov ID: NCT07607106
What this study is testing
- What it's testing
- This study is testing a new liquid treatment for people with long-lasting (chronic) wounds, such as venous leg ulcers or diabetic foot ulcers. These wounds can be difficult to heal because they often contain dead tissue and bacteria.
- Time commitment: about 4 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- A pure or mixed venous ulcer, or a diabetic, neuropathic, or neuroischemic foot ulcer, greater than or equal to 4 cm² and less than or equal to 30...
- A duration of the ulcer greater than or equal to 2 months and less than or equal to 2 years.
- Age over 60 years: due to the higher prevalence of ulcers in adults over 60 years of age.
- An ankle-brachial index between 0.6 and 1.3.
You likely can't join if
- Morbid obesity (BMI \> 35)
- History of cancer treatment in the last year
- Uncontrolled diabetes (Glycated Hemoglobin above 10 mg/dL)
- Uncontrolled hypertension (blood pressure readings greater than 140/90 mmHg)
- Patients with a known allergy to the components of the products under study.
- Patients with signs of infection or undergoing antibiotic therapy.
The study team makes the final eligibility decision.
Where it's taking place
- Santiago, Metropolitana de Santiago, Chile
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 4 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago, Metropolitana de Santiago, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.